Soluble immune markers in the different phases of chronic hepatitis B virus infection
Abstract Chronic hepatitis B virus (HBV) infection may follow four different consecutive phases, which are defined by virology as well as biochemical markers and differ in terms of prognosis and need for antiviral treatment. Currently, host responses reflected by immune markers are not considered in...
Guardado en:
Autores principales: | Steffen B. Wiegand, Bastian Beggel, Anika Wranke, Elmira Aliabadi, Jerzy Jaroszewicz, Cheng-Jian Xu, Yang Li, Michael P. Manns, Thomas Lengauer, Heiner Wedemeyer, Anke R. M. Kraft, Christine S. Falk, Markus Cornberg |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f7ac612f63a345c6b2c5dd3549909b29 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Chronic hepatitis C virus infection irreversibly impacts human natural killer cell repertoire diversity
por: Benedikt Strunz, et al.
Publicado: (2018) -
SOLUBLE FORMS OF MEMBRANOUS ANTIGENS IN SERUM OF PATIENTS WITH HEPATITIS C
por: T. V. Vishnevskaya, et al.
Publicado: (2014) -
Soluble urokinase plasminogen activator receptor as a marker for use of antidepressants.
por: Eva Haastrup, et al.
Publicado: (2014) -
Spatiotemporal analysis of soluble aggregates and autophagy markers in the R6/2 mouse model
por: M. J. Vijay Kumar, et al.
Publicado: (2021) -
Association of MiR-126 with soluble mesothelin-related peptides, a marker for malignant mesothelioma.
por: Lory Santarelli, et al.
Publicado: (2011)